ACA
WHWK

Acorn Capital Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Acorn Capital Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Hold
1,139,363
– – 1.42% 15
2026
Q1 		$3.93M Hold
1,139,363
– – 1.12% 15
2025
Q4 		$2.76M Hold
1,139,363
– – 0.93% 16
2025
Q3 		$2.16M Hold
1,139,363
– – 1.1% 16
2025
Q2 		$2.13M Hold
1,139,363
– – 1.39% 15
2025
Q1 		$2.03M Sell
1,139,363
-7,689
-0.7% -$20.1K 1.35% 15
2024
Q4 		$3.62M Buy
+1,147,052
New +$2.6M 1.95% 15

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acorn Capital Advisors's WHWK Position: Q2 2026 in Review

Acorn Capital Advisors held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 1,139,363 shares worth $5.22M. The position accounts for 1.42% of the portfolio, ranked #15.

Acorn Capital Advisors first reported a position in WHWK in Q4 2024 and has held it in 7 quarters since. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Acorn Capital Advisors held 1,139,363 shares of Whitehawk Therapeutics worth $5.22M as of Q2 2026.
  • Acorn Capital Advisors left its Whitehawk Therapeutics share count unchanged in Q2 2026.
  • Whitehawk Therapeutics made up 1.42% of Acorn Capital Advisors's portfolio in Q2 2026, its #15 holding.
  • Acorn Capital Advisors first reported a position in Whitehawk Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.